Company / CapEx per Share
United Therapeutics CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$11.61
FY2025
5-year range
$2.71 / $11.61
FY2021-FY2025
Trend
+121.6%
vs FY2024
Sector context
#3 of 192
Health Care
What the data says
Among 192 Health Care companies, United Therapeutics is in the top 2% for capex per share. CapEx per Share has increased for 5 consecutive years, from $1.35 in FY2020 to $11.61 in FY2025.
Based on SEC 10-K filings.
11.61 in FY2025 with a 5-year CAGR of +53.8%. Ranks 3rd among 192 companies in Health Care.
Improved from $5.01 to $11.61 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +55.7%
- 5-Year CAGR
- +53.8%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 192This company $11.61 Sector average $3.54
▼
+228.2% above sector average
Key checks
Key Insights
- United Therapeutics's capex per share has grown for 5 consecutive years.
- In FY2025, capex per share increased 121.6% year-over-year.
- Ranks #3 out of 192 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.61 | +121.6% |
| FY2024 | $5.24 | +4.7% |
| FY2023 | $5.01 | +62.7% |
| FY2022 | $3.08 | +13.4% |
| FY2021 | $2.71 | +100.9% |
| FY2020 | $1.35 | -29.6% |
| FY2019 | $1.92 | -55.0% |
| FY2018 | $4.26 | +267.9% |
| FY2017 | $1.16 | +39.6% |
| FY2016 | $0.83 | -21.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026